Alere announces cash dividend of $3.

Alere announces cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock Alere Inc. , a worldwide leader in fast diagnostics, today provides declared a money dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock . The dividend is payable on July 15, 2015 to holders of record of Series B stock at the close of business on July 1, 2015. Such payment covers the quantity of all dividends accrued from April 1, 2015 through June 30, 2015.By 3 months after randomization, 89 percent of the individuals in the early-therapy group got a plasma viral load of less than 400 copies per milliliter, in comparison with 9 percent in the delayed-therapy group. CD4 counts in the early-therapy group rose after the initiation of antiretroviral therapy, from a median of 442 cellular material per cubic millimeter at enrollment to 603 cellular material per cubic millimeter by 12 a few months, and the counts ongoing to rise throughout the follow-up period . A modest decline in CD4 counts was observed in the delayed-therapy group, from a median of 428 cellular material per cubic millimeter at enrollment to 399 cellular material per cubic millimeter by 12 months.